Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $21.57 Consensus Target Price from Brokerages
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price […]
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price […]
